Title: Caglic D, et al. Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain. J Med Chem. 2014 Feb 13;57(3):669-676.
1373205-30-1 | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid hydrochloride | AA00HUSS | MFCD23106119
1096841-92-7 | 2-chloro-N-(cyclopentylmethyl)acetamide | AA00K0PD | MFCD12166665
1114823-91-4 | 5-(4-aminophenyl)-1H,2H,3H,4H,7H,8H,9H-pyridazino[4,5-a]pyrrolizine-1,4-dione | AA019N4K | MFCD11505482
1384431-25-7 | 3-methoxy-5-(methoxycarbonyl)thiophene-2-sulfonic acid | AA019U3K | MFCD22056363
1193389-19-3 | 3-[(methylamino)methyl]benzamide hydrochloride | AA019WFL | MFCD12913057
1275835-34-1 | 6-chloro-N-(3,4-dihydro-2H-1-benzopyran-4-yl)pyrimidin-4-amine | AA019YCI | MFCD17293468
1240528-59-9 | [1-(6-Chloropyrazin-2-yl)-1h-1,2,3-triazol-5-yl]methanol | AA01A916 | MFCD16547633
1152531-66-2 | 4-[(1-methyl-1H-pyrazol-4-yl)methoxy]phenol | AA01AAQM | MFCD11181708
1311676-03-5 | 1-benzoyl-2-(piperidin-4-yl)azepane | AA01AH60 | MFCD19381852
1315365-39-9 | 3-fluoro-4-(1H-pyrazol-1-yl)benzene-1-sulfonamide | AA01AJCA | MFCD19382260
